KaydedilenlerDerginizi ekleyin

Dergiler / Marmara Medical Journal / 2018 / Volume: 31 Issue: 3

Skleroderma hastalarında soğuk stresin sağ ventrikülün fonksiyonu üzerine etkisi

The effect of cold stress on right ventricular function in patients with systemic sclerosis

Mustafa Yılmaztepe(Department of Cardiology, School of Medicine, Trakya University, Edirne, Turkey)
Meryem Aktoz(Department of Cardiology, School of Medicine, Trakya University, Edirne, Turkey)
Ersan Tatlı(Department of Cardiology, School of Medicine, Sakarya University)
Armağan Altun(Department of Cardiology, School of Medicine, Başkent University, Başkent, Turkey)
Sayfa
—
Yayın Tarihi
2018-10-31
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Amaç: Skleroderma (SSc)’da, pulmoner hipertansiyon ve sağ

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Amaç: Skleroderma (SSc)’da, pulmoner hipertansiyon ve sağ
📊
Temel Bulgular & Veri:Amaç: Skleroderma (SSc)’da, pulmoner hipertansiyon ve sağ
💡
Sonuç & Katkı:Amaç: Skleroderma (SSc)’da, pulmoner hipertansiyon ve sağ
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Systemic sclerosis · Echocardiography · Tissue Doppler

Özet

Amaç: Skleroderma (SSc)’da, pulmoner hipertansiyon ve sağ

Abstract

Objective: Pulmonary hypertension and right heart failure are poor

🔖

Bu Makaleye Atıf Yap

Yılmaztepe, M., Aktoz, M., Tatlı, E., Altun, A. (2018). Skleroderma hastalarında soğuk stresin sağ ventrikülün fonksiyonu üzerine etkisi. Marmara Medical Journal, Volume: 31 Issue: 3. https://doi.org/10.5472/marumj.472397

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (34)

  1. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-93.
  2. D’Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46:428-40.
  3. Clements PJ, Furst DE. Heart involvement in systemic sclerosis. Clin Dermatol 1994;12:267-75.
  4. Gashouta MA, Humbert M, Hassoun PM. Update in systemic sclerosis-associated pulmonary arterial hypertension. Presse Med 2014;43(10 Pt 2):e293-304. doi: 10.1016/j. lpm.2014.06.007
  5. Steen VD. Clinical manifestations of systemic sclerosis. Semin Cutan Med Surg 1998;17:48-54.
  6. Keir GJ, Nair A, Giannarou S, et al. Pulmonary vasospasm in systemic sclerosis: noninvasive techniques for detection. Pulm Circ 2015;5:498-505. doi: 10.1086/682221
  7. Wise RA, Wigley F, Newball HH, et al. The effect of cold exposure on diffusing capacity in patients with Raynaud’s phenomenon. Chest 1982;81:695-8.
  8. Sakamoto K, Houya I, Inoue K, et al. An imbalance in plasma prostanoids in patients with Raynaud’s phenomenon and pulmonary vasospasm. Eur Respir J 1999;13:137-44.
  9. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
  10. Shuck JW, Oetgen WJ, Tesar JT. Pulmonary vascular response during Raynaud’s phenomenon in progressive systemic sclerosis. Am J Med 1985;78:221-7.
  11. Mukerjee D, Yap LB, Ong V, et al. The myth of pulmonary Raynaud’s phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension. Ann Rheum Dis 2004;63:1627-31. doi: 10.1136/ard.2003.015289
  12. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233-70. doi: 10.1093/ehjci/jev014
  13. Wang YC, Huang CH, Tu YK. Pulmonary Hypertension and Pulmonary Artery Acceleration Time: A Systematic Review and Meta-Analysis. J Am Soc Echocardiogr 2018;31:201-10. e3. doi: 10.1016/j.echo.2017.10.016
  14. Ferri C, Giuggioli D, Sebastiani M, et al. Heart involvement and systemic sclerosis. Lupus 2005;14:702-7.
  15. Agoston G, Gargani L, Miglioranza MH, et al. Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis. Cardiovasc Ultrasound 2014;12:30. doi: 10.1186/1476-7120-12-30
  16. Ucar Elalmis O, Cicekcioglu H, Karagoz A, et al. Evaluation of aortic elastic properties in patients with systemic sclerosis. Turk Kardiyol Dern Ars 2014;42:635-42. doi: 10.5543/ tkda.2014.03162
  17. Poanta L, Dadu R, Tiboc C, et al. Systolic and diastolic function in patients with systemic sclerosis. Eur J Intern Med 2009;20:378-82. doi: 10.1016/j.ejim.2008.10.011
  18. D’Andrea A, Stisi S, Caso P, et al. Associations between left ventricular myocardial involvement and endothelial dysfunction in systemic sclerosis: noninvasive assessment in asymptomatic patients. Echocardiography 2007;24:587-97. doi: 10.1111/j.1540-8175.2007.00436.x
  19. Can I, Onat AM, Aytemir K, et al. Detecting subclinical biventricular impairment in scleroderma patients by use of pulsed-wave tissue Doppler imaging. Tex Heart Inst J 2009;36:31-7.
  20. Spethmann S, Rieper K, Riemekasten G, et al. Echocardiographic follow-up of patients with systemic sclerosis by 2D speckle tracking echocardiography of the left ventricle. Cardiovasc Ultrasound 2014;12:13. doi: 10.1186/1476-7120-12-13
  21. Faludi R, Kolto G, Bartos B, et al. Five-year follow-up of left ventricular diastolic function in systemic sclerosis patients: determinants of mortality and disease progression. Semin Arthritis Rheum 2014;44:220-7. doi: 10.1016/j. semarthrit.2014.04.001
  22. Saito M, Wright L, Negishi K, et al. Mechanics and prognostic value of left and right ventricular dysfunction in patients with systemic sclerosis. Eur Heart J Cardiovasc Imaging 2017 doi: 10.1093/ehjci/jex147
  23. Durmus E, Sunbul M, Tigen K, et al. Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension. Speckle-tracking echocardiographic study. Herz 2015;40:709-15. doi: 10.1007/s00059-014-4113-2 100 Yılmaztepe et al. Effect of cold stress on the right heart in scleroderma Marmara Medical Journal 2018; 31: 94-100
  24. Huez S, Roufosse F, Vachiery JL, et al. Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? Eur Respir J 2007;30:928-36. doi: 10.1183/09031936.00025607
  25. Lindqvist P, Caidahl K, Neuman-Andersen G, et al. Disturbed right ventricular diastolic function in patients with systemic sclerosis: a Doppler tissue imaging study. Chest 2005;128:755-63. doi: 10.1378/chest.128.2.755
  26. Cannon PJ, Hassar M, Case DB, et al. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) 1974;53:1-46.
  27. Alexander EL, Firestein GS, Weiss JL, et al. Reversible coldinduced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med 1986;105:661-8.
  28. Gustafsson R, Mannting F, Kazzam E, et al. Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet 1989;2(8661):475-9.
  29. Mizuno R, Fujimoto S, Saito Y, et al. Cardiac Raynaud’s phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study. Eur J Heart Fail 2010;12:268-75. doi: 10.1093/eurjhf/hfp198
  30. Quarta S, Galea N, Gigante A, et al. The cardiac magnetic resonance in the diagnosis of cardiac Raynaud phenomenon in a patient with systemic sclerosis: case report and review of literature. Expert Rev Clin Immunol 2016;12:251-5. doi: 10.1586/1744666X.2016.1134320
  31. Crosswhite P, Sun Z. Inhibition of phosphodiesterase-1 attenuates cold-induced pulmonary hypertension. Hypertension 2013;61:585-92. doi: 10.1161/ HYPERTENSIONAHA.111.00676
  32. Fahey PJ, Utell MJ, Condemi JJ, et al. Raynaud’s phenomenon of the lung. Am J Med 1984;76(2):263-9.
  33. Barr WG, Fahey PJ. Reduction of pulmonary capillary blood volume following cold exposure in patients with Raynaud’s phenomenon. Chest 1988;94:1195-9.
  34. Lampert E, Charloux A, Lonsdorfer J, et al. The concept of Raynaud’s phenomenon of the lung revisited. Am J Med 1996;101:468-71.